Stage II Non-Small Cell Lung Cancer
Also known as: Non-small Cell Lung Cancer Stage II / Nonsmall Cell Lung Cancer, Stage II / Lung Cancer Non-Small Cell Stage II / NSCLC Stage II / NSCLC, Stage II
Drug | Drug Name | Drug Description |
---|---|---|
DB11595 | Atezolizumab | A monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy. |
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |